Skip to main content
SpringerLink
Log in

References

  • Chapter
Acute Myelogenous Leukemia in Childhood

  • 38 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amadori S, Petti MC, de Francesco A, Chierichini A, Mastrovincenzo C, Testa MG, Mandelli F (1978) Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia ( ANLL ). Cancer 41: 1154–1160

    Article  PubMed  CAS  Google Scholar 

  2. Arlin Z, Kempin S, Mertelsmann R, Gee TS, Higgins C, Jhanwar S, Changani RSK, Clarkson B (1984) Primary therapy of acute promyelocytic leukemia: results of amsacrine and daunorubicin based therapy. Blood 63: 211–214

    PubMed  CAS  Google Scholar 

  3. Arlin Z, Ahmed T, Mittelmann A, Feldmann E, Mehta R, Weinstein P, Rieber E, Sullivan P, Baslund P (1987) A new regimen of amsacrine with high dose cytara- bine is safe and effective therapy for acute leukemia. J Clin Oncol 5: 371–375

    PubMed  CAS  Google Scholar 

  4. Arnold H, Bourseaux F, Brock N (1958) Neuartige Krebschemotherapeutika aus der Gruppe der zyklischen n-lost-phophamidester. Naturwissenschaften 45:64– 66

    Google Scholar 

  5. Arthur DC, Bloomfield CD (1983) Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 61: 994–998

    PubMed  CAS  Google Scholar 

  6. Arthur DC (1986) Genetics and cytogenetics of pediatric cancers. Cancer 58: 534–540

    Article  PubMed  CAS  Google Scholar 

  7. Baehner RL, Bernstein ID, Sather H, Higgins G, McCreadie S, Chard RL, Hammond D (1979) Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL. Med Pediatr Oncol 7: 127–139

    Article  PubMed  CAS  Google Scholar 

  8. Baehner RL, Bernstein ID, Sather H, Huggins G, McCreadie S, Chard RL, Hammond D (1984) Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Children’s Cancer Study Group. Cancer Treat Rep 68: 1269–1271

    PubMed  CAS  Google Scholar 

  9. Beguin Y, Bury J, Fillet G, Lennes G (1985) Treatment of acute nonlymphocytic leukemia in young and elderly patients. Cancer 56: 2587–2592

    Article  PubMed  CAS  Google Scholar 

  10. Benedetto P, Mertelsmann R, Szatrowski TH, Andreeff M, Gee T, Arlin Z, Kempin S, Clarkson B (1986) Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. J Clin Oncol 4:489– 495

    Google Scholar 

  11. Bennett JH (1845) Case of hypertrophy of the spleen and liver, in which death took place from suppuration of the blood. Edinb Med Surg J: 413–423

    Google Scholar 

  12. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Dalton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458

    Article  PubMed  CAS  Google Scholar 

  13. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Dalton DAG, Gralnick HR, Sultan C (1985) Criteria for diagnosis of acute leukemia of megakaryocyte li neage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med 103: 460–462

    PubMed  CAS  Google Scholar 

  14. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Dalton DAG, Gralnick HR, Sultan C (1985) Proposed revised critera for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann In-tern Med 103: 626–629

    Google Scholar 

  15. Berger R, Bernheim A, Daniel M-T, Valensi F, Sigaux F, Flandrin G (1985) Cytogenetic studies on acute myelomonocytic leukemia ( M4) with eosinophilia. Leukemia Res 9: 279–288

    Google Scholar 

  16. Bernard J, Bessis M (1948) Réflexions sur le traitement des leucoses aiguës par l’exsanguino-transfusion. Sang Par 19: 45–50

    CAS  Google Scholar 

  17. Bernard JF, Jaquillat CI, Boiron M, Najean Y, Seligmann M, Tanzer J, Weil M, Lortholary P (1967) Essai de traitement des leucémies aiguës lymphoblastiques et myéloblastiques par un antibiotique nouveau: la rubidomycine (13057 RP). Etude de 61 observations. Presse Med 75: 951–955

    PubMed  CAS  Google Scholar 

  18. Bernard JF, Weil M, Boiron M (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood 41: 489–496

    PubMed  CAS  Google Scholar 

  19. BMDP Statistical Software (1983) University of California Press, Berkeley

    Google Scholar 

  20. Boggs DR, Wintrobe MM, Cartwright GE (1962) The acute leukemias. Medicine 41: 163–225

    Article  PubMed  CAS  Google Scholar 

  21. Boggs DR, Wintrobe MM, Cartwright GE (1969) To treat or not to treat acute granulocytic leukemia. II. Arch Intern Med 123: 568–570

    Google Scholar 

  22. Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15

    Article  PubMed  CAS  Google Scholar 

  23. Bonadonna G, Valagussa P (1983) Comment on “The méthodologie dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with diasease-free-survival”. Cancer Treat Rep 67: 527–529

    PubMed  CAS  Google Scholar 

  24. Bradstock KF, Hoffbrand AV, Ganeshaguru K, Llewellin P, Patterson K, Wonke B, Prentice AG, Bennett M, Pizzolo G, Bollum FJ, Janossy G (1981) Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukaemia: an analysis by immunofluorescence. Br J Haematol 47: 133–143

    Article  PubMed  CAS  Google Scholar 

  25. Brandman J, Bukowski RM, Greenstreet R, Hewlett JS, Hoffman GC (1979) Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia. Cancer 44: 1062–1065

    Article  PubMed  CAS  Google Scholar 

  26. Breslow NE, Day NE (1980) The analysis of case-control studies. In: Davis W (ed): Statistical methods in cancer research. I ARC Scientific publications, vol 32. IARC, Lyon

    Google Scholar 

  27. Brodeur GM, Williams DL, Kalwinsky DK, Williams KJ, Dahl GV (1983) Cytogenetic features of acute nonlymphoblastic leukemia in 73 children and adoles-cents. Cancer Genet Cytogenet 8: 93–105

    Article  PubMed  CAS  Google Scholar 

  28. Bucsky P, Reiter A, Ritter J, Dopfer R, Riehm H for the BFM study group (1988) Die akute lymphoblastische Leukämie im Säuglingsalter: Ergebnisse aus fünf multizentrischen Therapiestudien ALL-BFM 1970-1986. Klin Pädiatr 200:177– 183

    Google Scholar 

  29. Büchner Th, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, Nowrousian MR, König HJ, Walter M, Wendt FC, Sodomann H, Hossfeld DK, von Paleske A, Löffler H, Gassmann W, Hëllriegel K-P, Fülle HH, Lunscken Ch, Emmerich B, Pralle H, Pees HW, Pfreundschuh M, Bartels H, Koeppen K-M, Schwerdtfeger R, Donhuijsen-Ant R, Mainzer K, Bonfert B, Köppler H, Zurborn K-H, Ranft K, Thiel JE, Heinecke A (1985) Intensified induction and consolidation with or without maintenance che motherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583–1589

    PubMed  Google Scholar 

  30. Burchenal JH, Murphy ML, Ellison RR, Sykes MP, Tan TC, Leone LA, Karnofsky DA, Craver LF, Dargeon HW, Rhoads CP (1953) Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied disease. Blood 8: 965–999

    PubMed  CAS  Google Scholar 

  31. Clift RA (1987) The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplant 2: 243–258

    PubMed  CAS  Google Scholar 

  32. Champlin R, Jacobs A, Gale RP, Elashoff R, Boccia R, Foon KA, Zighelboim J (1984) Prolonged survival in acute myelogenous leukemia without maintenance chemotherapy. Lancet 1: 894–896

    Article  PubMed  CAS  Google Scholar 

  33. Champlin R, Gale RP (1987) Acute myelogenous leukemia: recent advances in therapy. Blood 69: 1551–1562

    PubMed  CAS  Google Scholar 

  34. Chessels JM, O’Callaghan U, Hardisty RM (1986) Acute myeloid leukaemia in childhood: clinical features and prognosis. Br J Haematol 63: 555–564

    Article  Google Scholar 

  35. Choi SI, Simone JV (1976) Acute nonlymphocytic leukemia in 171 children. Med Pediatr Oncol 2: 119–146

    Article  PubMed  CAS  Google Scholar 

  36. Collins AJ, Bloomfleld CD, Peterson BA, McKenna RW, Edson JR (1978) Acute promyelocytic leukemia: management of the coagulopathy during daunorubicin- prednisone remission induction. Arch Intern Med 138: 1677–1680

    Article  PubMed  CAS  Google Scholar 

  37. Cox DR (1972) Regression models and life–tables. J R Statist Soc Bull 34:187– 220

    Google Scholar 

  38. Creutzig U, Schellong G (1981) Differenzierung der akuten Leukämien. Dtsch Med Wochenschr 106: 1303–1308

    Article  PubMed  CAS  Google Scholar 

  39. Creutzig U, Ritter J, Langermann H-J, Riehm H, Henze G, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kabisch H, Wahlen W, Löffler H, Schellong G (1983) Akute myeloische Leukämie bei Kindern: Ergebnisse der kooperativen Therapiestudie BFM-78 nach 3 3/4 Jahren. Klin Pädiatr 195: 152–160

    Article  PubMed  CAS  Google Scholar 

  40. Creutzig U, Schaaff A, Ritter J, Jobke A, Kaufmann U, Schellong G (1984) Akute myeloische Leukämie bei Kindern unter 2 Jahren: Untersuchungen und Behandlungsergebnisse bei 23 Kindern der AML-Therapiestudie BFM-78. Klin Pädiatr 196: 130–134

    Article  PubMed  CAS  Google Scholar 

  41. Creutzig U, Ritter J, Riehm H, Langermann H-J, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kaufmann U, Löffler H, Schellong G (1985) Improved treatment results in childhood acute myelogenous leukemia: a report of the German Cooperative Study AML–BFM-78. Blood 65: 298–304

    PubMed  CAS  Google Scholar 

  42. Creutzig U, Stahnke K, Pollmann H, Sutor A, Ritter J, Budde M, Schellong G (1987) The problem of early death in childhood AML. In: Büchner Th, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leukemias. Springer, Berlin Heidelberg New York, pp 524–529 (Haematology and blood transfusion, vol 30 )

    Google Scholar 

  43. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G (1987) Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Cancer 60: 3071–3079

    Article  PubMed  CAS  Google Scholar 

  44. Cutler SJ, Axtell L, Heise H (1967) Ten thousand cases of leukemia: 1940–1962. J Natl Cancer Inst 39: 993–1026

    PubMed  CAS  Google Scholar 

  45. Cuttner J, Conjalka MS, Reilly M, Goldberg J, Reisman A, Meyer RJ, Holland. JF (1980) Association of monocytic leukemia in patients with extreme leukocyto-sis. Am J Med 69: 555–558

    Article  PubMed  CAS  Google Scholar 

  46. Dahl GV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JV (1982) Cytokinetically based in duction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood 60: 856–863

    PubMed  CAS  Google Scholar 

  47. Dahl GV, Kalwinsky DK, Mirro J, Look AT (1987) A comparison of cytokinetically based versus intensive chemotherapy for childhood acute myelogenous leukemia. In: Büchner Th, Sehellong G, Hiddemann W, Ritter J, Urbanitz D (eds) Acute leukemias. Springer, Berlin Heidelberg New York, pp 83–87 (Haematology and Blood transfusion, vol 30 )

    Google Scholar 

  48. Damashek W (1969) The Di Guglielmo syndrome revisited. Blood 34: 567–572

    Google Scholar 

  49. Daly PA, Schiffer CA, Wiernik PH (1980) Acute promyelocyte leukemia-clinical management of 15 patients. Am J Hematol 8: 347–359

    Article  PubMed  CAS  Google Scholar 

  50. Dearth JC, Fountain KS, Smithson WA, Burgert EO, Gilchrist GS (1978) Extreme leukemic leukocytosis (blast crisis) in childhood. Mayo Clin Proc 53:207– 211

    Google Scholar 

  51. Economopoulos Th, Maragoyannis Z, Stathakis N, Gardikas E, Gardikas C (1980) Analysis of 75 cases of acute myeloid leukaemia classified according to the FAB classification. Acta Haematol (Basel) 63: 317–320

    Article  CAS  Google Scholar 

  52. Estey E, Keating MJ, McCredie KB, Bodey GP, Freireich EJ (1982) Causes of initial remission induction failure in acute myelogenous leukemia. Blood 60:309– 315

    Google Scholar 

  53. Estey E, Keating M, Plunkett W, McCredie K, Walters R, Kantarjian H, Beran M, Anderson B (1986) High dose continuous infusion cytosine arabinoside without anthracycline produces high CR rates in adults under age 50 with previously untreated AML. Blood 68 [Suppl 1]: 222

    Google Scholar 

  54. Farber S, Diamond LK, Mercer RD, Sylvester RF Jr, Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4- aminopteroylglutamic acid ( Aminopterin ). N Engl J Med 238: 787–793

    Google Scholar 

  55. Farber S, Schwachman H, Toch RT, Downing V, Kennedy BH, Hyde J (1950) The effect of ACTH in acute leukemia in childhood. In: Mote JR (ed) Proceedings of the first clinical ACTH conference. Blakiston, Philadelphia, p 328

    Google Scholar 

  56. Findley H, Steuber CP, Krischer JP, Ragab AH (1987) Pediatric oncology group study of in vitro clonal growth patterns of leukemic cells in childhood acute non-lymphocytic leukemia as a predictor of induction response. Cancer Res 47:4225– 4228

    Google Scholar 

  57. Foon KA, Yale C, Clodfelter K, Gale RP (1980) Posttransfusion hepatitis in acute myelogenous leukemia. Effect on survival. JAMA 244: 1806–1807

    Google Scholar 

  58. Fourth International Workshop on Chromosomes in Leukemia (1984) A prospective study in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11: 249–360

    Article  Google Scholar 

  59. Frei E III, Freireich EJ, Gehan E, Pinkel D, Holland JF, Selawry O, Haurani F, Spurr CL, Hayes DM, James GW, Rothberg H, Sodee DB, Rundles RW, Schroeder LR, Hoogstraten B, Wolman I J, Traggis DG, Cooper T, Gendel BR, Ebaugh F, Raylor R (1961) Studies of sequential and combination antimetabolit therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 18:431– 454

    Google Scholar 

  60. Frei E III, Freireich EJ (1965) Progress and perspectives in the chemotherapy of acute leukemia. Adv Chemother 2: 269–289

    PubMed  CAS  Google Scholar 

  61. Freund M, Link H, Diedrich H, Poliwoda H (1986) High dose ARA-C and VP16 in treatment of refractory or relapsing acute leukemia. J Cancer Res Clin Oncol [Suppl] 111: 107

    Article  Google Scholar 

  62. Gale RP (1987) The role of bone marrow transplantation in acutg myelogenous leukemia. In: Büchner Th, Sehellong G, Hiddemann W, Ritter J, Urbanitz D(eds) Acute leukemias. Springer, Berlin Heidelberg New York, pp 197–203 (Hae- matology and blood transfusion, vol 30)

    Google Scholar 

  63. George SL, Fernbach DJ, Vietti TJ, Sullivan MP, Lane DM, Haggard ME, Berry DH, Lonsdale D, Komp D (1973) Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958–1970. Cancer 32: 1542–1553

    Article  PubMed  CAS  Google Scholar 

  64. Goldie JH, Goldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66: 439–449

    PubMed  CAS  Google Scholar 

  65. Golomb HM, Vardiman JW, Rowley JD, Testa JR, Mintz U (1978) Correlations of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia. N Engl J Med 299: 603–619

    Article  Google Scholar 

  66. Green JA, Dawson AA, Fell LF, Murray S (1980) Measurement of drug dosage intensity in MVPP therapy in Hodgkin’s disease. Br J Clin Pharmacol 9:511– 514

    Google Scholar 

  67. Gunz F, Baikie AG (1974) Leukaemia, 3rd edn. Grune and Stratton, New York, pp 403–414

    Google Scholar 

  68. Habermalz HJ, Bamberg M (1986) The role of radiotherapy in pediatric oncology. Monogr. Paediatr 18: 39–55

    Google Scholar 

  69. Hagemeijer A, Pollack C (1986) Nonrandom chromosome aberrations in acute myelocytic leukemia. In: Becker R (ed) Chromosomes in Hematology. Interna-tional Symposium of the West German Cancer Center Essen, Münster. Zuckschwerdt, Munich, pp 29–41

    Google Scholar 

  70. Harris AL (1978) Leukostasis associated with blood transfusion in acute myeloid leukaemia. Br Med J 1: 1169–1171

    Article  PubMed  CAS  Google Scholar 

  71. Henderson ES, Wallace HJ, Yates J, Scharlau C, Rakowski I, Ellison RR, Holland JF (1975) Factors influencing prognosis in adult acute myelocytic leukemia. In: Fliedner TM, Perry S (eds) Advances in the biosciences. Pergamon, New York, pp 71–82

    Google Scholar 

  72. Henze G, Langermann H-J, Lampert F, Neidhardt A, Riehm H (1979) Die Studie zur Behandlung der akuten lymphoblastischen Leukämie 1971–1974 der Deutschen Arbeitsgemeinschaft für Leukämie-Forschung und -Behandlung im Kindesalter e. V. Analyse der prognostischen Bedeutung von Initialbefunden und Therapievarianten. Klin Pädiatr 191: 8-20

    Google Scholar 

  73. Henze G, Langermann H-J, Wulf M, Creutzig U, Riehm H (1981) Bedeutung von Daunorubicin für die kurative Behandlung der akuten lymphoblastischen Leukämie im Kindesalter. Beitr Onkol 9: 437 - 445

    Google Scholar 

  74. Henze G, Langermann H-J, Fengler R, Brandeis M, Evers KG, Gadner H, Hinderfeld L, Jobke A, Kornhuber B, Lampert F, Lasson U, Ludwig R, Müller- Weihrich S, Neidhardt M, Nessler G, Niethammer D, Rister M, Ritter J, Schaaff A, Schellong G, Stollmann B, Treuner J, Wahlen W, Weinel P, Wehinger H, Riehm H (1982) Therapiestudie BFM 79/81 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: intensivierte Reinduktions- therapie für Patientengruppen mit unterschiedlichem Rezidivrisiko. Klin Pädiatr 194: 195–203

    Article  PubMed  CAS  Google Scholar 

  75. Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes CN, Herzig GP (1983) High dose cytosine-arabinoside therapy for refractory leukemia. Blood 62:361– 369

    Google Scholar 

  76. Hiddemann W, Harbott J, Haas HO, Budde M, Büchner T, Lampert F (1987) Nachweis von Aberrationen des Karyotyps bei Kindern mit akuten Leukämien: eine vergleichende Analyse von Zytogenetik und Durchflußzytophotometrie. Klin Pädiatr 199: 161–164

    Article  PubMed  CAS  Google Scholar 

  77. Hiddemann W, Kreutzmann H, Straif K, Ludwig W-D, Mertelsmafln R, Planker M, Donhuijsen-Ant R, Lengfelder E, Arlin Z, Büchner T (1987) High-dose cyto- sine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. Semin Oncol 14: 73–77

    PubMed  CAS  Google Scholar 

  78. Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR, Glick JH (1984) High dose cytarabine and m-AMSA is effective therapy in relapsed acute nonlympho- blastic leukemia. J Clin Oncol 2: 545–549

    PubMed  CAS  Google Scholar 

  79. Hoelzer D (1988) Randomisierte vs. nicht-randomisierte Phase-III-Studien. In: Creutzig U (ed) Therapiestudien bei bösartigen Neubildungen. Schriftenreihe zum Programm der Bundesregierung Forschung und Entwicklung im Dienste der Gesundheit, vol 7, pp 87–89

    Google Scholar 

  80. Holmes R, Keating MJ, Cork A, Broach Y, Trujillo J, Dalton WT Jr, McCredie KB, Freireich EJ (1985) A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(pl3q22). Blood 65: 1071–1078

    PubMed  CAS  Google Scholar 

  81. Hoogstraten B, Schroeder LR, Freireich EJ, Frei E III, Holland J, Pinkel D, Vogel P, Mills StD, Bürgert EO Jr, Hayes DM, Spurr ChL, Kurkcuoglu M, Storrs R, Ebaugh F, Wolman I J, Haurani F, Gendel B, Gehan E (1960) Cyclophosphamide (Cytoxan) in acute leukemia, preliminary report. A study by the acute leukemia cooperative group B. Cancer Chemother Rep 8: 116–119

    Google Scholar 

  82. Howard JP, Albo V, Newton WA Jr (1968) Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia. Cancer 21: 341–345

    Google Scholar 

  83. Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281–1288

    PubMed  CAS  Google Scholar 

  84. Hryniuk W, Levine MN (1986) Analysis of dose intensity for adjuvant chemo-therapy trials in stage II breast cancer. J Clin Oncol 4: 1162–1170

    PubMed  CAS  Google Scholar 

  85. Hug V, Keating M, McCredie K, Hester J, Bodey GP, Freireich EJ (1983) Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer 52: 773–779

    Article  PubMed  CAS  Google Scholar 

  86. Hurd DD, Peterson BA, McKenna RW, Bloomfield CD (1981) VP16–213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features. Med Pediatr Oncol 9: 251–255

    Article  PubMed  CAS  Google Scholar 

  87. Huth E (1969) Geschichtlicher Abriß der Leukoseforschung und -therapie. In: Hertl M, Landbeck G (eds) Leukämie bei Kindern. Thieme, Stuttgart, pp 1–2

    Google Scholar 

  88. Janossy G, Hoffbrand AV, Greaves MF, Ganeshaguru K, Pain C, Bradstock KF, Prentice HG, Kay HEM, Lister TA (1980) Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukemia: a multiparameter analysis of 300 cases. Br J Haematol 44: 221–234

    Article  PubMed  CAS  Google Scholar 

  89. Johnson JS, Armstrong JG, Gorman M, Burnett JP (1963) The vinca-alkaloids: a new class of oncolytic agents. Cancer Res 23: 1390–1395

    PubMed  CAS  Google Scholar 

  90. Kaatsch R, Michaelis J (1988) Jahresbericht 1987 des Kinderkrebsregisters Mainz. Universität Mainz

    Google Scholar 

  91. Kalwinsky DK, Dahl GV, Mirro J, Look ATh (1985) Cyclophosphamide/etoposide: effective reinduction therapy for children with acute nonlymphocytic leukemia in relapse. Cancer Treat Rep 69: 887–889

    PubMed  CAS  Google Scholar 

  92. Kantaijian HM, Keating MJ, Walters RS (1986) Acute promyelocyte leukemia: MD Anderson Hospital experience. Am J Med 80: 789–797

    Google Scholar 

  93. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observa-tions. J Am Stat Assoc 53: 457–481

    Article  Google Scholar 

  94. Keating MJ, Smith TL, Gehan EA, McCredie KB, Bodey GP, Spitzer G, Hersh E, Gutterman J, Freireich EJ (1980) Factors related to length of complete remission in adult acute leukemia. Cancer 45: 2017–2029

    Article  PubMed  CAS  Google Scholar 

  95. Keating MJ, Smith TL, Gehan EA, McCredie KB, Bodey GP, Freireich EJ (1982) A prognostic factor analysis for use in the development of predictive models for response in adult leukemia. Cancer 50: 457–465

    Article  PubMed  CAS  Google Scholar 

  96. Keating MJ (1982) Early identification of potentially cured patients with acute myelogenous leukemia - a recent challenge. In: Bloomfield CD (ed) Adult leukemias 1. Nijhoff, The Hague, pp 237–263

    Google Scholar 

  97. Keinänen M, Griffin JD, Bloomfield CD, Machnicki J, de la Chapelle A (1988) Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N Engl J Med 318: 1153–1158

    Google Scholar 

  98. Knapp W, Majdic O, Rumpold H, Bettelheim P, Kraft D, Liszka K, Forster O, Lutz D (1981) Myeloid differentiation antigens as defined by monoclonal anti-bodies. In: Knapp W (ed) Leukemia markers. Academic, London, pp 207–213

    Google Scholar 

  99. Kömel HW (1978) Die intrathekale Gabe von Zytostatika. Nervenarzt 49:685–696

    Google Scholar 

  100. Lampert F, Harbott J, Ritterbach J, Ludwig WD, Fonatsch C, Schwamborn D, Stier B, Gnekow A, Gerein V, Stollmann B, Jobke A, Janka-Schaub G (1988) T-cell acute childhood lymphoblastic leukemia with chromosome 14qll anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients. Blut 56: 117 - 123

    Article  PubMed  CAS  Google Scholar 

  101. Landbeck G (1977) 10 Jahre Deutsche Arbeitsgemeinschaft für Leukämie-For-schung und -Behandlung im Kindesalter e.V. Klin Pädiatr 189:1–6

    Google Scholar 

  102. Lau B, Jäger G, Huhn D, Jehn U, Thierfelder S, Dörmer P (1982) Auer rod positive myelocytic leukemic cells in diffusion chambers: differentiation along the eosinophilic pathway. Blut 45: 332 - 338

    Article  Google Scholar 

  103. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD (1983) Association of inv(16) (pl3q22) with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetie-clinicopathologic asso-ciation. N Engl J Med 309: 630–636

    Article  PubMed  Google Scholar 

  104. Le Beau MM, Diaz MO, Karin M, Rowley JD (1985) Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukemia. Nature 313: 709–711

    Article  PubMed  Google Scholar 

  105. Lee EJ, Pollak A, Leavit RD, Testa JR, Schiffer CA (1987) Minimally differen-tiated acute nonlymphocytic leukemia: A distinct entity. Blood 70: 1400–1406

    Google Scholar 

  106. Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR, Freireich EJ (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96: 133–139

    PubMed  CAS  Google Scholar 

  107. Lester TJ, Johnson JW, Cuttner J (1985) Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyper- leukocytosis. Am J Med 79: 43–48

    Article  PubMed  CAS  Google Scholar 

  108. Lewis JP, Linman HW, Marshall GJ (1977) Randomized clinical trial of cyto- sine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia. Cancer 39: 1387–1396

    Article  PubMed  CAS  Google Scholar 

  109. Lichtman MA, Rowe JM (1982) Hyperleukocytie leukemias: rheological, clini-cal, and therapeutic considerations. Blood 60: 279–283

    PubMed  CAS  Google Scholar 

  110. Linch DC, Burnett AK (1986) Clinical study of ABMT in acute myeloid leukemia. Clin Haematol 15: 167–185

    PubMed  CAS  Google Scholar 

  111. Löffler H (1976) Eosinophilen-Leukämie. In: Stacher A, Höcker P (eds) Erkran-kungen der Myelopoese. Urban and Schwarzenberg, Munich, pp 412–417

    Google Scholar 

  112. Ludwig WD, Herrmann F, Gatzke A, Budde M, Creutzig U, Ritter J, Schellong G (1987) Surface marker analysis by monoclonal antibodies: a valuable technique in childhood acute myeloid leukemia. In: Büchner Th, Schellong G, Hid demann W, Urbanitz D, Ritter J (eds) Acute leukemias. Springer, Berlin Heidelberg New York, pp 418–422 (Haematology and Blood transfusion, vol 30 )

    Google Scholar 

  113. Marty M, Lepage E, Guy H (1987) Remission induction and maintenance mo-dalities in acute myeloid leukemia (AML): a multicentric randomized study. In: Büchner Th, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leu-kemias. Springer, Berlin Heidelberg New York, pp 50–56 (Haematology and Blood transfusion, vol 30 )

    Google Scholar 

  114. McKenna RW, Bloomfield CD, Dick F, Nesbit ME, Brunning RD (1975) Acute monoblastic leukemia: diagnosis and treatment of ten cases. Blood 46:481– 494

    Google Scholar 

  115. Medical Research Council’s Working Party on Leukemia in Adults (1975) The relation between morphology and other features of acute myeloid leukemia, and their prognostic significance: a report on leukaemia in adults. Br J Haematol 31: 165–180

    Article  Google Scholar 

  116. Mertelsmann R, Thaler HT, To L, Gee TS, McKenzie S, Schauer P, Friedmann A, Arlin Z, Cirrincione C, Clarkson B (1980) Morphological classification, re-sponse to therapy, and survival in 263 adult patients with acute nonlymphoblas- tic leukemia. Blood 56: 773–781

    PubMed  CAS  Google Scholar 

  117. Michaelis J, Kaatsch P (1987) Die kooperative Dokumentation von Malignomen im Kindesalter. Auswertungen von über 6000 Neuerkrankungen in der BRD seit 1980. Monatsschr Kinderheilkd 135: 427–431

    PubMed  CAS  Google Scholar 

  118. Mirchandani I, Palutke M (1983) Acute megakaryoblastic leukemia. Cancer 50: 2866–2872

    Article  Google Scholar 

  119. Moore MA, Spitzer G, Williams N, Metealf D, Buckley J (1974) Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclas-sification of leukemia according to in vitro characteristics. Blood 44: 1–18

    PubMed  CAS  Google Scholar 

  120. Moreno H, Castleberry RP, McCann WP (1977) Cytosine arabinoside and 6- thioguanine in the treatment of childhood acute myeloblasts leukemia. Cancer 40: 998 - 1004

    Article  PubMed  CAS  Google Scholar 

  121. Neame PB, Soamboonsrup P, Browman GP, Benger RM, Edwin W, Wilson C, Walker IR, Saeed N, McBride JA (1986) Classifying acute leukemia by immu- nophenotyping: a combined FAB–immunological classification of AML. Blood 68: 1355–1362

    PubMed  CAS  Google Scholar 

  122. Nishikawa A, Nakamura Y, Nobori U, Aoki T, Higashino H, Matsui T, Kobayashi Y, Yamashita M, Unishi G (1987) Acute monocytic leukemia in chil-dren. Response to VP-16-213 as a single agent. Cancer 60: 2146–2149

    Article  PubMed  CAS  Google Scholar 

  123. Odom LF, Gordon EM (1984) Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophylotoxin. Blood 64:875– 882

    Google Scholar 

  124. O’Reilly RJ (1983) Allogeneic bone marrow transplantation: current status and future directions. Blood 62: 941–964

    PubMed  Google Scholar 

  125. Paterson E, Haddow A, Thomas I, Watkinson JM (1946) Leukemia treated with urethane, compared with deep X-ray therapy. Lancet 1: 677–682

    Article  PubMed  CAS  Google Scholar 

  126. Passe S, Mike V, Mertelsmann R, Gee TS, Clarkson BD (1982) Acute nonlym- phoblastic leukemia. Cancer 50: 1462–1471

    Article  PubMed  CAS  Google Scholar 

  127. Pearson OH, Eliel LP, Rawson RW, Dobrinen K, Rhoads CP (1949) ACTH- and cortisone-induced regression of lymphoid tumors in man: a preliminary report. Cancer 2: 943 - 945

    Article  PubMed  CAS  Google Scholar 

  128. Pessano S, Palumbo A, Ferrero D, Pagliardi GL, Bottero L, Lai SK, Meo P, Carter C, Hubell H, Lange B, Rovera G (1984) Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal anybodies. Blood 64: 275–279

    PubMed  CAS  Google Scholar 

  129. Peterson BA (1982) Acute nonlymphocytie leukemia in the elderly: biology and treatment. In: Bloomfield CD (ed) Adult leukemias 1. Nijhoff, The Hague, pp 199–210

    Google Scholar 

  130. Peto R, Pike MC (1973) Conservatism of the approximation £(0-E)2/E in the logrank test for survival data or tumor incidence data. Biometrics 29: 579–584

    Article  PubMed  CAS  Google Scholar 

  131. Plüss HJ, Hitzig WH (1980) Die akuten myeloischen Leukämien im Kindesalter. Schweiz Med Wochenschr 110: 1459–1462

    PubMed  Google Scholar 

  132. Preisler HD, Rustum Y, Henderson ES, Bjornsson S, Creaven PJ, Higby DJ, Freeman A, Gailami S, Naeher C (1979) Treatment of acute nonlymphocytic leukemia: use of an anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 53: 455–464

    PubMed  CAS  Google Scholar 

  133. Preisler HD (1980) Prediction of response to chemotherapy in acute myelocytic leukemia. Blood 56: 361–367

    PubMed  CAS  Google Scholar 

  134. Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchinson JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, Mclntyre OR, Kaan SK (1981) Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 58: 1203–1212

    PubMed  CAS  Google Scholar 

  135. Rand JJ, Maloney WD, Sise HS (1969) Coagulation defects in acute promyelocyte leukemia. Arch Intern Med 123: 39–47

    Article  PubMed  CAS  Google Scholar 

  136. Redmond C, Fisher B, Wienand HS (1983) The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. Cancer Treat Rep 6: 519–526

    Google Scholar 

  137. Rees JKH, Gray RG, Swirsky D, Hayhoe FGJ (1986) Principal results of the Medical Research Council’s 8th acute myeloid leukemia trial. Lancet 2:1236– 1241

    Google Scholar 

  138. Reizenstein P, Giannoulis NE, Johannsson NO (1980) Predicting response to combination chemotherapy in acute myeloblastic leukemia - a way to individualize treatment. Acta Med Scand 207: 321–325

    Article  PubMed  CAS  Google Scholar 

  139. Riehm H, Gadner H, Welte K (1977) Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes - Erfahrungsbericht nach 6 Jahren. Klin Pädiatr 189: 89–102

    PubMed  CAS  Google Scholar 

  140. Riehm H, Gadner H, Henze G, Langermann H-J, Odenwald (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol Oncol 2: 299–306

    Google Scholar 

  141. Riggs CE, Tipping SJ, Angelou JE, Bachur NR, Wiernik PH (1983) Human pharmacokinetics of continuous infusion adriamycin ( ADR ). ASCO abstracts, p 32

    Google Scholar 

  142. Ritter J, Creutzig U, Hiddemann W, Schellong G (1987) Mitoxantron in Kombination mit hochdosiertem ARA-C als Therapiemöglichkeit bei der AML im Kindesalter. Fortschr Antimikrob Antineopl Chemother 6-9: 1517–1521

    Google Scholar 

  143. Ritter J, Vormoor J, Creutzig U, Schellong G (1989) Prognostic significance of Auer rods in childhood AML: results of the studies AML-BFM-78 and -83. Med Pediatr Oncol 17: 202–209

    Article  PubMed  CAS  Google Scholar 

  144. Rudnick SA, Cadman EC, Capizzi RL (1979) High dose cytosine arabinoside ( HDARAC) in refractory acute leukemia. Cancer 44: 1189–1193

    Google Scholar 

  145. Sandberg AA (1986) The chromosomes in human leukemia. Semin Hematol 23: 201–217

    PubMed  CAS  Google Scholar 

  146. Sandler RM, Liebmann HA, Patch MJ, Teitelbaum A, Levine AM,Weinstein DI (1983) Antithrombin III and antiactivated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin. Cancer 51: 681–685

    CAS  Google Scholar 

  147. Sariban E, Oliver C, Corash L, Cossmann J, Whang-Peng J, Jaffe ES, Gralnick HR, Poplack DG (1984) Acute megakaryoblastic leukemia in childhood. Cancer 54: 1423–1428

    Article  PubMed  CAS  Google Scholar 

  148. Schellong G, Creutzig U, Ritter J (1985) Treatment of acute myelogenous leu-kemia in children. Med Oncol Tumor Pharmacother 2: 17–25

    PubMed  CAS  Google Scholar 

  149. Schellong G (1988) Konsekutiv-Studien (pädiatrische Erfahrungen). In: Creutzig U (ed) Therapiestudien bei bösartigen Neubildungen. Schriftenreihe zum Programm der Bundesregierung Forschung und Entwicklung im Dienste der Gesundheit, vol 7, pp 90–92

    Google Scholar 

  150. Schrappe M, Beck J, Brandeis WE, Feickert H-J, Gadner H, Graf N, Havers W, Henze G, Jobke A, Kornhuber B, Kühl J, Lampert F, Müller-Weihrich St, Nie-thammer D, Reiter A, Rister M, Schellong G, Tausch W, Weinel P, Riehm H (1987) Die Behandlung der akuten lymphoblastischen Leukämie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81. Klin Pädiatr 199: 133–150

    Article  PubMed  CAS  Google Scholar 

  151. Schwartz RS, Mackintosh R, Halpern J, Schrier StL, Greenberg PL (1984) Mul-tivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer 54: 1672–1681

    Article  PubMed  CAS  Google Scholar 

  152. Second MIC Cooperative Study Group (1988) Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 68: 487–494

    Article  Google Scholar 

  153. Simon JH, Tebbi CK, Freeman AI, Brecher ML, Green DM, Sandberg AA (1987) Acute megakaryoblastic leukemia associated with mosaic Down’s syndrome. Cancer 60: 2515–2520

    Article  PubMed  CAS  Google Scholar 

  154. Simone JV, Verzosa MS, Rudy JA (1975) Initial features and prognosis in 363 children with acute lymphoblastic leukemia. Cancer 36: 2099–2108

    Article  PubMed  CAS  Google Scholar 

  155. Smith IE, Powles R, Clink HMD, Jameson B, Kay HEM, Mc Elwain TJ (1977) Early deaths in acute myelogenous leukemia. Cancer 39: 1710–1714

    Article  PubMed  CAS  Google Scholar 

  156. Southwest Oncology Group (1974) Cytarabine for acute leukemia in adults: ef-fects of schedule on therapeutic response. Arch Intern Med 133: 251–259

    Article  Google Scholar 

  157. Steuber CP, Humphrey GB, McMillan CW, Vietti TJ (1978) Remission induc-tion in acute myelogenous leukemia using cytosine arabinoside synchronization: a Southwest Oncology Group Study. Med Pediatr Oncol 4: 337–342

    Article  PubMed  CAS  Google Scholar 

  158. Sullivan KM, Deeg HJ, Sanders JE (1984) Late complications after marrow transplantation. Semin Hematol 21: 53–63

    PubMed  CAS  Google Scholar 

  159. Sultan C, Deregnaucourt J, Ko YW, Imbert M, Ricard-D’Agay MF, Gouault- Heilmann M, Brun B (1981) Distribution of 250 cases of acute myeloid leu-kaemia ( AML) according to the FAB classification and response to therapy. Br J Haematol 47: 545–551

    Google Scholar 

  160. Sutor AH, Kremens B, Creutzig U, Ritter J, Schellong G (1982) Haemostase- und Fibrinolyseparameter bei akuter myeloischer Leukämie (AML) im Kindes-alter. In: van de Loo J, Asbeck F (eds) Haemostase, Thrombophilie und Arte-riosklerose. Schattauer, Stuttgart, pp 340–343

    Google Scholar 

  161. Tobelem G, Jacquillat C, Chastang C, Auclerc MF, Lechevallier T, Weil M, Daniel MT, Flandrin G, Harrousseau JL, Schaison G, Boiron M, Bernard J (1980) Acute monoblastic leukemia: a clinical and biological study of 74 cases. Blood 55: 71–76

    PubMed  CAS  Google Scholar 

  162. Toronto Leukemia Study Group (1986) Results of chemotherapy for unselected patients with acute myeloblasts leukemia: effect of exclusions on interpretation of results. Lancet 1: 786–792

    Google Scholar 

  163. Tricot G, Broeckert-van Orshoven A, Casteels-van Daele M, van den Berghe H (1981) 8/21 translocation in acute myeloid leukaemia. Scand J Haematol 26: 168–176

    Google Scholar 

  164. Tulliez M, Breton-Gorius J (1979) Three types of Auer bodies in acute leukemia, visualization of their protein by negative contrast after Peroxydase cytochemistry. Lab Invest 41: 419–426

    PubMed  CAS  Google Scholar 

  165. Ullrich O (1932) Zur Systematik aregeneratorischer und hyperplastischer Reak-tionen des Blutsystems. Z Kinderheilkd 53: 487–492

    Article  Google Scholar 

  166. Van der Reijden HJ, van Rhenen DJ, Lansdorp PM, van’t Veer MB, Langenhuijsen MM AC, Engelfriet CP, von dem Borne EGK (1983) A comparison of surface marker analysis and FAB classification in acute myeloid leukemia. Blood 61: 443–448

    Google Scholar 

  167. Van Wering ER, Kamps WA (1986) Acute leukemia in infants: a unique pattern of acute nonlymphocytic leukemia. Am J Pediatr Hematol Oncol 8: 220–224

    Article  PubMed  Google Scholar 

  168. Vernant JP, Brun B, Mannoni P, Dreyfus B (1979) Respiratory distress of hyper- leukocytic granulocytic leukemias. Cancer 44: 264–268

    Article  PubMed  CAS  Google Scholar 

  169. Viana MB, Maurer HS, Ferenc C (1980) Subclassification of acute lymphoblas-tic leukemia in children: analysis of the reproducibility of morphological criteria and prognostic implications. Br J Haematol 44: 383–388

    Article  PubMed  CAS  Google Scholar 

  170. Vogler WR, Winton EF, Gordon DS, Raney MR, Go B, Meyer L (1984) A ran-domized trial of post-remission therapy in acute myelogenous leukemia for the Southeastern Cancer Study Group. Blood 63: 1039–1045

    PubMed  CAS  Google Scholar 

  171. Weil M, Jacquillat CI, Gemon-Auclerc MF, Chastang CL, Israel V, Boiron M, Bernard J (1976) Acute granulocytic leukemia: treatment of the disease. Arch Intern Med 136: 1389–1395

    Article  PubMed  CAS  Google Scholar 

  172. Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E (1980) Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303: 473–478

    Article  PubMed  CAS  Google Scholar 

  173. Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelbert RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319

    Google Scholar 

  174. Weinstein H, Grier H, Gelber R, Camitta B, Link M, Dolerey M, Price K (1987) Postremission induction intensive sequential chemotherapy for children with AML - treatment results and prognostic factors. In: Büchner Th, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leukemias. Springer, Berlin Heidelberg New York, pp 88–92 (Haematology and Blood transfusion, vol 30 )

    Google Scholar 

  175. Whittaker JA, Withey J, Powell DEB, Parry TE, Khurshid M (1979) Leukemia classification: a study of the accuracy of diagnosis in 456 patients. Br J Haematol 41: 177–184

    Article  PubMed  CAS  Google Scholar 

  176. Whittaker JA, Reizenstein P, Callender ST, Cornwell GG, Delamore IW, Gale RP, Gobbi M, Jacobs P, Lantz B, Maiolo AT, Rees JKH, van Slyck EJ, Vu Van H (1981) Long survival in acute myelogenous leukaemia: an international colla-borative study. Br Med J 282: 692 - 695

    Google Scholar 

  177. Wiernik PH, Serpiek AA (1970) Factors effecting remission and survival in adult acute nonlymphocytic leukemia ( ANLL ). Medicine 49: 505–513

    Google Scholar 

  178. Wiernik PH, Glidewell OJ, Hoagland HC, Brunner KW, Spurr CL, Cuttner J, Silver RT, Carey RW, DelDuca V, Kung FH, Holland JF (1979) A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia. Med Pediatr Oncol 6: 261–277

    Article  PubMed  CAS  Google Scholar 

  179. Yates JG, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosife H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchinson JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF (1982) Cytosine ara- binoside with daunorubicin or adriamycin for therapy of acute myelocytic leu-kemia: a CALGB study. Blood 60: 454–462

    PubMed  CAS  Google Scholar 

  180. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke Ph J, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May WSt, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR (1986) Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315: 141–147

    Article  PubMed  CAS  Google Scholar 

  181. Yunis JJ, Bloomfield CD, Ensrud K (1981) All patients with acute nonlympho-cytic leukemia may have a chromosomal defect. N Engl J Med 305: 135–139

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Kinderklinik, Albert-Schweitzer-Straße 33, 4400, Münster, Germany

    Privatdozentin Dr. med. Ursula Creutzig

Authors
  1. Privatdozentin Dr. med. Ursula Creutzig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Professor Dr. med. Jörg Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Professor Dr. med. Günther Schellong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Kinderklinik, Albert-Schweitzer-Straße 33, 4400, Münster, Germany

    Ursula Creutzig

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Creutzig, U., Ritter, J., Schellong, G. (1990). References. In: Creutzig, U., Ritter, J., Schellong, G. (eds) Acute Myelogenous Leukemia in Childhood. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75351-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75351-0_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52070-2

  • Online ISBN: 978-3-642-75351-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation